تخطي إلى المحتوى الرئيسي

Spastic paraplegia type 3A

Spastic paraplegia type 3A is one of a group of genetic disorders known as hereditary spastic paraplegias. These disorders are characterised by muscle stiffness (spasticity) and weakness in the lower limbs (paraplegia). Hereditary spastic paraplegias are often divided into two types: pure and complex. The pure types involve only the lower limbs, while the complex types also involve other areas of the body; additional features can include changes in vision, changes in intellectual functioning, difficulty walking, and disturbances in nerve function (neuropathy). Spastic paraplegia type 3A is usually a pure hereditary spastic paraplegia, although a few complex cases have been reported.

الوصف

Spastic paraplegia type 3A is one of a group of genetic disorders known as hereditary spastic paraplegias. These disorders are characterised by muscle stiffness (spasticity) and weakness in the lower limbs (paraplegia). Hereditary spastic paraplegias are often divided into two types: pure and complex. The pure types involve only the lower limbs, while the complex types also involve other areas of the body; additional features can include changes in vision, changes in intellectual functioning, difficulty walking, and disturbances in nerve function (neuropathy). Spastic paraplegia type 3A is usually a pure hereditary spastic paraplegia, although a few complex cases have been reported.

In addition to spasticity and weakness, which typically affect both legs equally, people with spastic paraplegia type 3A can also experience progressive muscle wasting (amyotrophy) in the lower limbs, reduced bladder control, an abnormal curvature of the spine (scoliosis), loss of sensation in the feet (peripheral neuropathy), or high arches of the feet (pes cavus). The signs and symptoms of spastic paraplegia type 3A usually appear before the age of 10; the average age of onset is 4 years. In some affected individuals the condition slowly worsens over time, sometimes leading to a need for walking support.

Inheritance patterns

The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.

Other names

Spastic paraplegia 3

Spastic paraplegia 3A

SPG3A

Related patient information and medicines

الشلل الدماغي

Patient information leaflet

الشلل الدماغي

This may be before the baby is born, during the birth or soon after birth. What is cerebral palsy. Cerebral palsy is a name for a group of life-long conditions that have problems with muscle function and control. It is caused by brain injury or abnormal development of the brain that occurs while a child's brain is still developing. Types of.

خلل التوتر العضلي

Patient information leaflet

خلل التوتر العضلي

ت خلل التوتر العضلي is a lasting or frequently recurring and unwanted (involuntary) muscle contraction. It can affect one or more muscles in the body. There is no cure; however, there are different types of treatment which can help. Secondary dystonia Secondary means the dystonia ... It is not caused by your genetic make-up. Some neurological conditions.

تلف الأعصاب بعد حقن فوق الجافية

Patient information leaflet

تلف الأعصاب بعد حقن فوق الجافية

ت spinal injection Spinal anaesthetic is given directly into the fluid that surrounds your الورم الدموي فوق الجافية الفقري cord (called the cerebrospinal fluid). The injection can be a local anaesthetic or a medicine to relieve pain. The risk of longer... Nerve damage to both legs (paraplegia) or death occurs between 1 in 54,500 to 1 in 141,500 الورم الدموي فوق الجافية الفقري or epidural.

تخفيف الألم باستخدام الإيبيدورال بعد الجراحة

Patient information leaflet

تخفيف الألم باستخدام الإيبيدورال بعد الجراحة

The content of this leaflet is used with the permission of the Royal College of Anaesthetists , the professional body responsible for the speciality throughout the UK, ensuring the quality of patient care through the maintenance of standards in anaesthesia, critical care and pain medicine. What is an epidural. An epidural is used for giving pain.

ضمور العضلات

Patient information leaflet

ضمور العضلات

بعض genes control the proteins needed for muscle fibres to work properly. Genetic mutations can affect these genes, which are involved in MD. The 'faulty' gene in MD means that one of the proteins needed by muscle cells cannot be made correctly. The protein will either be lacking or will be a 'faulty' protein that does not work well. This leads.

مرض باجيت العظمي

Patient information leaflet

مرض باجيت العظمي

Paget's disease of bone affects the structure of parts of one or more bones. In most cases it causes no symptoms and does not need treatment. Symptoms develop in some cases and pain in the affected part of bone... What is Paget's disease of bone. Paget's disease of bone was first described by Sir James Paget in 1877. (It is a different condition.

قراءة إضافية ومراجع

تاريخ المقال

تمت كتابة المعلومات على هذه الصفحة ومراجعتها من قبل أطباء مؤهلين.
  • 27 Apr 2021 | أحدث إصدار
  • 1 Mar 2015 | نُشر في الأصل

انضم إلى المحادثة

شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.

تنويه: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

صيدلية إلكترونية وعلاجات وخدمات صحية

وصول بسيط إلى العلاجات والخدمات الصحية الموثوقة عبر الإنترنت.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

اشترك في النشرة الإخبارية للمرضى

جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.

يرجى إدخال عنوان بريد إلكتروني صالح

من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.